FDAFDA · Alimentos y medicamentos·N.º oficial D-757-2015
Levodopa or L-Dihydroxyphenylalanine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Publicado el 29 de abril de 2015 · Inicio del retiro: 14 de noviembre de 2014
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Detalles del retiro
- Fabricante
- Attix Pharmaceuticals
- Distribuidor
- Nationwide to compounding pharmacies and research organizations.
- Lote
- All lots repackaged and distributed between 01/05/12 to 02/12/15
- Clasificación de riesgo
- Class II
- Área (FDA)
- drug
- País
- Canada